Market Recap — July 29, 2026
Recap of insider activity, SEC filings, and market-moving news for July 29, 2026.
Last generated Sep 17, 2026, 4:58 PM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Sanara MedTech to Be Acquired by MiMedx in $35/Share Cash-and-Stock Deal
Sanara MedTech to be Acquired by MiMedx Group for $35.00 Per Share in Cash and Stock
Synergy CHC Loses Costco, Its 58% Revenue Customer — Survival at Risk
Inotiv exits Chapter 11 with $180M in fresh financing and a complete equity wipeout
Grant Thornton Advisors to Acquire CBIZ in $5 Billion All-Cash Deal at $55/Share
Processa Acquires Vidya Therapeutics with $200M PIPE to Advance BTK Inhibitor
Processa Acquires Vidya Therapeutics in Reverse Merger, Raises $200M PIPE to Advance BTK Inhibitor
Starbucks Raises Guidance Again as Turnaround Delivers 7.9% Comp Growth
AtaiBeckley Files Proxy for $3.91B Eli Lilly Acquisition, Board Unanimously Recommends Vote FOR
SoftVest Locks In Support for $2.2B PBT-US Land Guild Merger with Voting and $71M Backstop
Meta Plunges 10% After-Hours on Q2 Profit Drop, Weak Guidance
Microsoft Jumps 9% on Q4 Beat, $175B Capex Plan, and Bullish Azure Guidance
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Sanara MedTech to be Acquired by MiMedx Group for $35.00 Per Share in Cash and Stock
Synergy CHC Loses Costco, Its 58% Revenue Customer — Survival at Risk
Grant Thornton Advisors to Acquire CBIZ in $5 Billion All-Cash Deal at $55/Share
Processa Acquires Vidya Therapeutics with $200M PIPE to Advance BTK Inhibitor
Processa Acquires Vidya Therapeutics in Reverse Merger, Raises $200M PIPE to Advance BTK Inhibitor
Starbucks Raises Guidance Again as Turnaround Delivers 7.9% Comp Growth
Meta Plunges 10% After-Hours on Q2 Profit Drop, Weak Guidance
Microsoft Jumps 9% on Q4 Beat, $175B Capex Plan, and Bullish Azure Guidance
J&J Slashes 2026 EPS Guidance by ~5% Despite Steady Sales Outlook
Microsoft Guides FY2027 Capex Growth, Q1 Spend Over $50B as AI Buildout Continues
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.